Etiopathogenesis of hemolytic reactions in total artificial heart recipients

Artificial Organs

Volumn 21, Issue 12, 1997, Pages 1268-1276

  Vašků, Jaromír ^a   Urbánek, Petr ^b  

^a Vacord Bioengineering Res Company   (Czech Republic)

^b HP Medica GmbH   (Germany)

Author keywords

Exogenous and endogenous hemolytic factors; Role of red blood cell membrane resistance; Total artificial heart hemolysis as multifactorial state

Indexed keywords

ANIMALS; CELLS; CLINICAL RESEARCH; CYTOLOGY; DIAPHRAGMS; HEMOGLOBIN; MINERALOGY;

EXOGENOUS AND ENDOGENOUS HEMOLYTIC FACTOR; EXTRACORPOREAL CIRCULATION; HAEMOLYSIS; HEMOLYTIC REACTION; MEMBRANE RESISTANCE; RED BLOOD CELL; ROLE OF RED BLOOD CELL MEMBRANE RESISTANCE; THROMBUS FORMATION; TOTAL ARTIFICIAL HEART HEMOLYSIS AS MULTIFACTORIAL STATE; TOTAL ARTIFICIAL HEARTS;

BLOOD;

METHYLDOPA;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL HEART; BLOOD PUMP; CELL MEMBRANE RESISTANCE; ERYTHROCYTE LIFESPAN; ERYTHROCYTE MEMBRANE; EXTRACORPOREAL CIRCULATION; HEMOLYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOGENESIS;

ANIMALIA;

EID: 0031473595     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00487.x     Document Type: Article

References (25)

1. Vašků J. Artificial heart. Pathophysiology of the artificial heart and of cardiac assist devices. Acta Fac Med Univ Brun JE Purkynje 1982:397.
2. Vašků J. Brno experiments in the long-term survival with total artificial heart. Acta Fac Med Univ Brun JE Purkynje 1984:622.
3. Vašků J. A contribution to the assessment of pathophysiology in long-term total artificial heart recipients. In: Unger F, ed. Assisted circulation 3. Berlin: Springer, 1989:340-76.
4. Vašků J. Perspectives of total artificial heart research as a modelling system for general physiology and pathophysiology. In: Akutsu T, Koyanagi H, eds. Heart replacement, Artificial heart 4. Tokyo: Springer, 1993:161-71.
5. Vašků J, Urbánek P, Dostál M, Vašků J. The applicability of experimental experience with the total artificial heart to its clinical use. Int J Artif Organs 1992;15:307-11.
6. Vašků J. Vašků J, Dostál M, Guba P, Vašků A, Urbánek P, Necǎs J, Doležel S, Cídl K, Pavlícěk V, Bednařík B. Evaluation study of calves with total artificial heart (TAH) surviving for 218-293 days of pumping. Int J Artif Organs 1990;13: 830-6.
7. Petz LD. Drug induced immune hemolysis. N Engl J Med 1985;31:510-1.
8. Vašků J. Calcification of the driving diaphragm in total artificial heart. Czech Med 1987;10:16-28.
9. Vašků J, Urbánek P. Electron microscopic study of driving diaphragms in long term survival with a total artificial heart. Artif Organs 1995;19:344-54.
10. Vašků J. The changes of the TAH driving diaphragms after a long term pumping. In: Akutsu T, Koyanagi H, eds. Heart replacement, Artificial heart 5. Tokyo: Springer, 1996:53-65.
11. Mašek J, Vašků J, Dostál M, Černý J, Guba P, Pavlíček V, Urbánek P, Trbušek V, Vašků A, Plocková J, Šotolová O, Mozdřeňová J. Doležel S, Smutný M. Vašků J. Testing the clinical type of blood pumps TNS-BRNO VII/kl/B. The analysis of clinical condition of the red blood component. Scripta Medica Fac Med Univ Brunensis 1988;61:199-208.
12. van Aken WG. Interaction of blood cells with materials: Red cells and leucocytes. In: Davids S, ed. Polymers: Their properties and blood compatibility. Kluwer: Academic Publishers, 1989:13-9.
13. Wurzinger LJ, Opitz R, Hckstein H. Mechanical blood trauma: An overview. Angeiologie 1986;38:81-97.
14. Kramer C, Sand P, Bleifeld W. Blutströmung und mechanische Hämolyse. Biomed Tech 1971;16:164-8.
15. Wiebalck A, Flameng W. Hemolysis with the F21 hemopump. Int J Artif Organs 1995;18:365-71.
16. Reddy SB, Pater JL, Pym J, Amstrong PV. Hemolytic anemia following insertion of lonescu-Shiley mitral valve bioprosthesis. Can Med Ass J 1984;131:1469-70.
17. Velker JA, McIntire LV, Lynch EC. Alteration of erythrocyte deformability due to shear stress as assessed by multipore filters. Trans Am Soc Artif Intern Organs 1977;23:732-5.
18. Akutsu T. Current pathophysiologic problems with the total artificial heart. In: Atsumi K, Maekawa M, Ota K, eds. Progress in artificial organs, Vol 1, No. 204, Cleveland: ISAO Press, 1983:162-4.
19. Kolff WJ, DeVries WC, Joyce LD, Olsen DB, Jarvik RK, Nielsen S, Hastings L, Anderson J, Anderson F, Menlove R. Lessons learned from Dr. Barney Clark, the first patient with an artificial heart. In: Atsumi K, Maekawa M. Ota K, eds. Progress in artificial organs, Vol 1, No. 204, Cleveland: ISAO Press, 1983:165-74.
20. Wampler RK, Moise JC, Frazier OH, Olsen DB. In vivo evaluation of a peripheral vascular access-axial flow blood pump. Trans Am Soc Artif Intern Organs 1988;34:450-4.
21. Brain MC. Microangiopathic hemolytic anemia. N Engl J Med 1969;81:833-5.
22. Hjelm S, Ostling S, Persson A. The loss of certain cellular components from human erythrocytes during hypotonie hemolysis in the presence of dextran. Acta Physiol Scand 1966; 67:43.
23. Fairley NH. Fate of extracorpuscular circulating hemoglobin. Br Med J 1940;2:213-9.
24. Wellhausen SR, Ward RA, Johnson GS, DeVries WC. Immunologic complication of long-term implantation of total artificial heart. J Clin Immunol 1988;8:307-17.
25. Vašků J, Urbánek P. Constructional and functional characteristics of recent total artificial heart models TNS BRNO VII, VIII, and IX, Artif Organs 1995;19:535-43.